Determination of a new antiulcer agent, YJA-20379-2, in human plasma and urine by high-performance liquid chromatography.
A high-performance liquid chromatographic method was developed for the determination of a new antiulcer agent, YJA-20379-2, in human plasma and urine. The sample preparation was simple: 2.5-volume of acetonitrile was added to the biological sample to deproteinize. A 50-microliter aliquot of the supernatant was injected onto a C18 reversed-phase column. The mobile phase employed was methanol-0.1M Sørensen phosphate buffer of pH 7.0-H2O (75:2:25, v/v/v), and was run at a flow-rate of 1.0 ml/min. The column effluent was monitored by ultraviolet detector at 295 nm. The retention time for YJA-20379-2 was approximately 7.0 min. The detection limits for YJA-20379-2 in human plasma and urine were both 100 ng/ml. The coefficients of variation of the assay (within-day and between-day) were generally low (below 9.16%) for both the human plasma and urine. No interference from endogenous substances was found.
Yoon
W H
WH
College of Pharmacy, Seoul National University, Shinlim-Dong, Kwanak-Gu, Korea.
Kim
S H
SH
Chung
S Y
SY
Chang
M S
MS
Choi
W S
WS
Sohn
S K
SK
Lee
M G
MG
D000897:Anti-Ulcer Agents / Q000097:blood* / Q000652:urine*; D002851:Chromatography, High Pressure Liquid; D006801:Humans; D007093:Imidazoles / Q000097:blood* / Q000652:urine*
D000897:Anti-Ulcer Agents; D007093:Imidazoles; C105753:YJA 20379-2